---
$id: https://graph.org.ai/products/commodity/51442602
$type: Product
source: UNSPSC
code: "51442602"
title: "Phenolsulfonphthalein"
class: "51442600"
classTitle: "Sodium-based radiopharmaceuticals, imaging agents, media, and tracers"
family: "51440000"
familyTitle: "Radiopharmaceuticals and contrast media"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Phenolsulfonphthalein

**UNSPSC Code**: 51442602
**Class**: [Sodium-based radiopharmaceuticals, imaging agents, media, and tracers](Sodium-based radiopharmaceuticals, imaging agents, media, and tracers.mdx)
**Family**: [Radiopharmaceuticals and contrast media](../Radiopharmaceuticals and contrast media.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a diagnostic reagent with the molecular formula C19H14O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I6G9Y0J1OJ, chemically known as 4,4-(3h-2,1-benzoxathiol-3-ylidene)diphenol s,s-dioxide but more generally known as phenolsulfonphthalein, which bears US NIH Compound Identifier 4766. The European Medicines Agency schedules Phenolsulfonphthalein in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14835MIG. The World Health Organization schedules phenolsulfonphthalein in its Anatomical Therapeutic Chemical (ATC) Classification.

